Looking for our Business Solutions? Click here:CloudQuote APIsContact Us
Home
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Is It Too Late to Buy AppLovin Stock After Its Nearly 300% Rise Over the Past Year?fool.com
Via The Motley Fool · May 12, 2025
Should You Buy This Beaten-Down Artificial Intelligence (AI) Stock on the Dip?fool.com
Via The Motley Fool · May 12, 2025
3 Things I'll Be Watching in Walmart's Upcoming Earnings Report (and 2 I'll Ignore)fool.com
Tariff-prompted turbulence has made two usually important pieces of information much less useful.
Via The Motley Fool · May 12, 2025
2 No-Brainer Dividend Stocks to Buy With $2,000 Right Nowfool.com
American Express and Realty Income are both reliable blue-chip dividend stocks.
Via The Motley Fool · May 12, 2025
This Undervalued Restaurant Stock Is Up About 10% Since a Member of the Audience Mistakenly Asked About It at Berkshire Hathaway's Annual Meetingfool.com
Via The Motley Fool · May 12, 2025
Economic Data Forecasts For The Weeks Of May 12 And 19talkmarkets.com
Projections for upcoming economic data releases, including CPI, PPI, GDP.
Via Talk Markets · May 12, 2025
Earnings Scheduled For May 12, 2025benzinga.com
Via Benzinga · May 12, 2025
Prediction: Nvidia Just Received Its First Wall Street Sell Rating -- and More Will Follow After May 28fool.com
Multiple headwinds suggest the party is over for Wall Street's artificial intelligence (AI) darling.
Via The Motley Fool · May 12, 2025
I Used to Say Claiming Social Security at 62 Was a Bad Move. Here's Why I Was Wrong.fool.com
Via The Motley Fool · May 12, 2025
Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarketbenzinga.com
What Happened: On Sunday, President Donald Trump announced on Truth Social that he plans to sign what he called the "most consequential executive order" in U.S. history, aimed at lowering prescription drug prices.
Via Benzinga · May 12, 2025
Meet the Monster Stock That Continues to Crush the Marketfool.com
Via The Motley Fool · May 12, 2025
US-China Dial Down Trade War With 90-Day Tariff Truce; Futures Point to Bumper Wall Street Openstocktwits.com
This would mean the combined 145% tariffs on Chinese imports will be reduced to 10% by May 14, while the 20% duties related to fentanyl will stay in place.
Via Stocktwits · May 12, 2025
Tata Steel Near Key Support Ahead Of Q4 Results: SEBI RA Rohit Mehta Eyes Breakout If Volumes Holdstocktwits.com
The stock is forming a rounded bottom pattern and remains 18% below its all-time high, Mehta said.
Via Stocktwits · May 12, 2025
FAA Mulls Cutting Flights At Newark Airport Amid Staffing Woes And Equipment Failures: Reportbenzinga.com
FAA considering reducing flights at Newark Airport due to disruptions caused by equipment and staff shortages.
Via Benzinga · May 12, 2025
Yes Bank Surges On SMBC Deal: SEBI RA Orchid Research Predicts Rally To ₹25stocktwits.com
Analyst sees upside in Yes Bank, citing strong momentum indicators and volume support.
Via Stocktwits · May 12, 2025
Warren Buffett's Cash Pile at Berkshire Hathaway Just Hit a Record $348 Billion -- and That's Terrible News for Wall Streetfool.com
The Oracle of Omaha's short-term actions paint a potentially worrisome picture for investors.
Via The Motley Fool · May 12, 2025
Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trialbenzinga.com
Eli Lilly and Company's Zepbound demonstrated superior weight reduction compared to Novo Nordisk's Wegovy in a 72-week head-to-head trial.
Via Benzinga · May 12, 2025
Monday.Com Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analystsmonday-com
Via Benzinga · May 12, 2025
WEBTOON (WBTN) Reports Q1: Everything You Need To Know Ahead Of Earnings
Digital storytelling platform WEBTOON (NASDAQ:WBTN) will be reporting results tomorrow after market close. Here’s what to expect.
Via StockStory · May 12, 2025
Visualized: Post-Pandemic GDP Growth Recovery, By Regiontalkmarkets.com
Despite the strong recovery over the last five years, U.S. GDP growth is now projected to hit a speed bump following the Trump administration’s reciprocal tariffs announced in April 2025.
Via Talk Markets · May 12, 2025
India Pharma Stocks Slip: SEBI RA Adarsh Nimborkar Breaks Down Risks From Trump’s Drug Pricing Pushstocktwits.com
Trump’s Most Favored Nation (MFN) drug pricing policy could significantly compress margins, disrupt product pipelines, and force Indian firms to rework their U.S. strategies.
Via Stocktwits · May 12, 2025
Trump's Millionaire Tax More Of A Symbolic Gesture Than Step Towards Reducing Inequality, Warn Experts: 'It's Going To Give A Lot Of Republicans Heartburn'benzinga.com
President Donald Trump's proposed millionaire tax, which aims to increase the tax rate on income over $2.5 million, is being seen as largely symbolic and unlikely to significantly impact revenue or inequality by experts.
Via Benzinga · May 12, 2025
Intuitive Machines Q1 Earnings Preview: Future Lunar Missions, Government Contracts In Focusstocktwits.com
The stock has been pressured this year after the IM-2 mission lunar lander Athena landed on its side, 250 meters from its intended landing site.
Via Stocktwits · May 12, 2025
MAS Q1 Earnings Call: Tariff Headwinds and Leadership Transition Shape Outlook
Home-building design and manufacturing company Masco Corporation (NYSE:MAS) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 6.5% year on year to $1.8 billion. Its non-GAAP profit of $0.87 per share was 5.3% below analysts’ consensus estimates.
Via StockStory · May 12, 2025
Monster Beverage Retail Traders Stay Bullish Despite Surprise Q1 Revenue Fall: Here's What Analysts Saystocktwits.com
The company attributed the decline to changes in ordering patterns of bottlers and distributors in the U.S. and Europe and foreign currency headwinds.
Via Stocktwits · May 12, 2025